Cyclopropaneacetic acid → HCID 178520149, Verbindung
Reaktionsgleichung
Cl.Cl.Cl.[O:4]1[C:8]2=[C:9]([N:13]3[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][C@H:21]4[CH2:26][CH2:25][C@H:24]([NH2:27])[CH2:23][CH2:22]4)[CH2:15][CH2:14]3)[N:10]=[CH:11][CH:12]=[C:7]2[CH2:6][CH2:5]1.[CH:28]1([CH2:31][C:32](O)=[O:33])[CH2:30][CH2:29]1>>[CH:28]1([CH2:31][C:32]([NH:27][C@H:24]2[CH2:25][CH2:26][C@H:21]([CH2:20][CH2:19][N:16]3[CH2:17][CH2:18][N:13]([C:9]4[N:10]=[CH:11][CH:12]=[C:7]5[CH2:6][CH2:5][O:4][C:8]=45)[CH2:14][CH2:15]3)[CH2:22][CH2:23]2)=[O:33])[CH2:30][CH2:29]1Komponenten
3
Versuchsvorschrift
The title compound, white solid (48 mg, 73%), MS (ISP) m/z=413.5 [(M+H)+], mp 197.5° C., was prepared in accordance with the general method of example 6 from trans-4-{2-[4-(2,3-dihydro-furo[2,3-c]pyridin-7-yl)-piperazin-1-yl]-ethyl}-cyclohexylamine trihydrochloride (intermediate B) (70.4 mg, 0.16 mmol) 2-cyclopropyl-acetic acid.
Quellen und Nachweise
- ORD-Eintrag
- ord-9c041fe79bdd4c9798efefb030272d78
- Quelldatensatz
- uspto-grants-2013_06
- Patentnummer
- US08470828B2
Notizen zur Reaktion
Wird geladen…